These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 8521580)
1. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Ruzicka M; Skarda V; Leenen FH Circulation; 1995 Dec; 92(12):3568-73. PubMed ID: 8521580 [TBL] [Abstract][Full Text] [Related]
2. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy. Lear W; Ruzicka M; Leenen FH Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479 [TBL] [Abstract][Full Text] [Related]
3. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Ruzicka M; Yuan B; Harmsen E; Leenen FH Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912 [TBL] [Abstract][Full Text] [Related]
4. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy. Ruzicka M; Leenen FH Circulation; 1995 Jan; 91(1):16-9. PubMed ID: 7805197 [TBL] [Abstract][Full Text] [Related]
5. Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Leenen FH; Skarda V; Yuan B; White R Am J Physiol; 1999 Jan; 276(1):H317-25. PubMed ID: 9887046 [TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin. Ruzicka M; Keeley FW; Leenen FH Circulation; 1994 Oct; 90(4):1989-96. PubMed ID: 7923689 [TBL] [Abstract][Full Text] [Related]
7. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Leenen FH; White R; Yuan B Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2410-6. PubMed ID: 11709406 [TBL] [Abstract][Full Text] [Related]
8. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Ruzicka M; Yuan B; Leenen FH Circulation; 1994 Jul; 90(1):484-91. PubMed ID: 8026035 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes. Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313 [TBL] [Abstract][Full Text] [Related]
10. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525 [TBL] [Abstract][Full Text] [Related]
11. Protective action of angiotensin converting enzyme inhibitors on cardiac hypertrophy in the aortic-banded rat. Kurosawa Y; Kojima K; Kato M; Ohashi R; Minami K; Narita H Jpn Heart J; 1999 Sep; 40(5):645-54. PubMed ID: 10888384 [TBL] [Abstract][Full Text] [Related]
12. Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy. Mukawa H; Toki Y; Shimauchi A; Matsui H; Morishima I; Okumura K; Ito T; Hayakawa T J Hypertens; 1997 Sep; 15(9):1027-32. PubMed ID: 9321751 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure. Brower GL; Levick SP; Janicki JS Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3057-64. PubMed ID: 17308006 [TBL] [Abstract][Full Text] [Related]
14. Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats. Morimoto A; Nishikimi T; Yoshihara F; Horio T; Nagaya N; Matsuo H; Dohi K; Kangawa K Hypertension; 1999 May; 33(5):1146-52. PubMed ID: 10334802 [TBL] [Abstract][Full Text] [Related]
15. Effect of enalapril and quinapril on forearm vascular ACE in man. Lyons D; Webster J; Benjamin N Eur J Clin Pharmacol; 1997; 51(5):373-8. PubMed ID: 9049577 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload. Tokioka-Akagi T; Fujimori A; Shibasaki M; Inagaki O; Yanagisawa I Jpn J Pharmacol; 2001 May; 86(1):79-85. PubMed ID: 11430476 [TBL] [Abstract][Full Text] [Related]
17. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939 [TBL] [Abstract][Full Text] [Related]
18. Acute and long-term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters. Benetos A; Albaladejo P; Levy BI; Safar ME J Hypertens Suppl; 1994 Jul; 12(4):S21-9. PubMed ID: 7965270 [TBL] [Abstract][Full Text] [Related]
19. Prolonged inhibition of local angiotensin-converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats. Nakajima T; Yamada T; Setoguchi M J Cardiovasc Pharmacol; 1992 Jan; 19(1):102-7. PubMed ID: 1375675 [TBL] [Abstract][Full Text] [Related]
20. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Luo JD; Zhang WW; Zhang GP; Guan JX; Chen X Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):903-8. PubMed ID: 10561812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]